723 related articles for article (PubMed ID: 21566416)
1. Managing your patient with gout: a review of treatment options.
Doghramji PP
Postgrad Med; 2011 May; 123(3):56-71. PubMed ID: 21566416
[TBL] [Abstract][Full Text] [Related]
2. Treatment and prophylaxis of gout flare in the clinic: an office-based approach to gout management.
Lieberman JA
Postgrad Med; 2011 Nov; 123(6):151-65. PubMed ID: 22104464
[TBL] [Abstract][Full Text] [Related]
3. The current state of care in gout: Addressing the need for better understanding of an ancient disease.
Zychowicz ME; Pope RS; Graser E
J Am Acad Nurse Pract; 2010 Nov; 22 Suppl 1():623-36. PubMed ID: 21054636
[TBL] [Abstract][Full Text] [Related]
4. Progress in the pharmacotherapy of gout.
Sundy JS
Curr Opin Rheumatol; 2010 Mar; 22(2):188-93. PubMed ID: 20110792
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and management of acute gout.
Conway N; Schwartz S
Med Health R I; 2009 Nov; 92(11):356-8. PubMed ID: 19999893
[TBL] [Abstract][Full Text] [Related]
6. Clinical efficacy and safety of successful longterm urate lowering with febuxostat or allopurinol in subjects with gout.
Becker MA; Schumacher HR; MacDonald PA; Lloyd E; Lademacher C
J Rheumatol; 2009 Jun; 36(6):1273-82. PubMed ID: 19286847
[TBL] [Abstract][Full Text] [Related]
7. Casebook consults: improving outcomes in gout (multimedia activity).
Doghramji PP; Mandell BF; Pope RS
Am J Med; 2012 Aug; 125(8):S1. PubMed ID: 22840678
[TBL] [Abstract][Full Text] [Related]
8. Febuxostat compared with allopurinol in patients with hyperuricemia and gout.
Becker MA; Schumacher HR; Wortmann RL; MacDonald PA; Eustace D; Palo WA; Streit J; Joseph-Ridge N
N Engl J Med; 2005 Dec; 353(23):2450-61. PubMed ID: 16339094
[TBL] [Abstract][Full Text] [Related]
9. Gout: an update.
Eggebeen AT
Am Fam Physician; 2007 Sep; 76(6):801-8. PubMed ID: 17910294
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis and management of gout.
Pittman JR; Bross MH
Am Fam Physician; 1999 Apr; 59(7):1799-806, 1810. PubMed ID: 10208700
[TBL] [Abstract][Full Text] [Related]
11. Gout: nonsteroidal anti-inflammatory drugs and colchicine to prevent painful flares during early urate-lowering therapy.
Kuritzky L; Panchal R
J Pain Palliat Care Pharmacother; 2010 Dec; 24(4):397-401. PubMed ID: 21133750
[TBL] [Abstract][Full Text] [Related]
12. Updates in the management of gout.
Keith MP; Gilliland WR
Am J Med; 2007 Mar; 120(3):221-4. PubMed ID: 17349440
[TBL] [Abstract][Full Text] [Related]
13. Effect of prophylaxis on gout flares after the initiation of urate-lowering therapy: analysis of data from three phase III trials.
Wortmann RL; Macdonald PA; Hunt B; Jackson RL
Clin Ther; 2010 Dec; 32(14):2386-97. PubMed ID: 21353107
[TBL] [Abstract][Full Text] [Related]
14. CaseBook challenges: Managing gout, hyperuricemia and comorbidities -- dialogue with the experts.
Bakris GL; Doghramji PP; Keenan RT; Silber SH
Am J Med; 2014 Jan; 127(1):S1. PubMed ID: 24268074
[TBL] [Abstract][Full Text] [Related]
15. 2011 Recommendations for the diagnosis and management of gout and hyperuricemia.
Hamburger M; Baraf HS; Adamson TC; Basile J; Bass L; Cole B; Doghramji PP; Guadagnoli GA; Hamburger F; Harford R; Lieberman JA; Mandel DR; Mandelbrot DA; McClain BP; Mizuno E; Morton AH; Mount DB; Pope RS; Rosenthal KG; Setoodeh K; Skosey JL; Edwards NL;
Postgrad Med; 2011 Nov; 123(6 Suppl 1):3-36. PubMed ID: 22156509
[TBL] [Abstract][Full Text] [Related]
16. A new perspective on the pharmacoeconomics of colchicine.
Wertheimer AI; Davis MW; Lauterio TJ
Curr Med Res Opin; 2011 May; 27(5):931-7. PubMed ID: 21370937
[TBL] [Abstract][Full Text] [Related]
17. The management of gout at an academic healthcare center in Beijing: a physician survey.
Fang W; Zeng X; Li M; Chen LX; Schumacher HR; Zhang F
J Rheumatol; 2006 Oct; 33(10):2041-9. PubMed ID: 17014019
[TBL] [Abstract][Full Text] [Related]
18. Managing gout: how is it different in patients with chronic kidney disease?
El-Zawawy H; Mandell BF
Cleve Clin J Med; 2010 Dec; 77(12):919-28. PubMed ID: 21147946
[TBL] [Abstract][Full Text] [Related]
19. Nonsteroidal anti-inflammatory drugs and colchicine to prevent gout flare during early urate-lowering therapy: perspectives on alternative therapies and costs.
Peterson DM
J Pain Palliat Care Pharmacother; 2010 Dec; 24(4):402-4. PubMed ID: 21133751
[TBL] [Abstract][Full Text] [Related]
20. Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial.
Schumacher HR; Becker MA; Wortmann RL; Macdonald PA; Hunt B; Streit J; Lademacher C; Joseph-Ridge N
Arthritis Rheum; 2008 Nov; 59(11):1540-8. PubMed ID: 18975369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
